Search Results

There are 16090 results for: content related to: Preoperative Treatment With an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Receptor Blocker Has No Beneficial Effect on the Development of New-Onset Atrial Fibrillation After Off-Pump Coronary Artery Bypass Graft Surgery

  1. Aldosterone antagonists for preventing the progression of chronic kidney disease

    Intervention Review

    The Cochrane Library

    Davide Bolignano, Suetonia C Palmer, Sankar D Navaneethan and Giovanni FM Strippoli

    Published Online : 29 APR 2014, DOI: 10.1002/14651858.CD007004.pub3

  2. Antihypertensive treatment for kidney transplant recipients

    Intervention Review

    The Cochrane Library

    Nicholas B Cross, Angela C Webster, Philip Masson, Philip J O'Connell and Jonathan C Craig

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD003598.pub2

  3. Non-immunosuppressive treatment for IgA nephropathy

    Intervention Review

    The Cochrane Library

    Sharon Reid, Peggy M Cawthon, Jonathan C Craig, Joshua A Samuels, Donald A Molony and Giovanni FM Strippoli

    Published Online : 16 MAR 2011, DOI: 10.1002/14651858.CD003962.pub2

  4. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome

    Intervention Review

    The Cochrane Library

    Yizhi Chen, Arrigo Schieppati, Xiangmei Chen, Guangyan Cai, Javier Zamora, Giovanni A Giuliano, Norbert Braun and Annalisa Perna

    Published Online : 16 OCT 2014, DOI: 10.1002/14651858.CD004293.pub3

  5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients

    Intervention Review

    The Cochrane Library

    Ling Zhang, Xiaoxi Zeng, Ping Fu and Hong Mei Wu

    Published Online : 23 JUN 2014, DOI: 10.1002/14651858.CD009120.pub2

  6. You have free access to this content
    Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

    Cardiovascular Therapeutics

    Volume 30, Issue 3, June 2012, Pages: e156–e166, Marsha A. Raebel

    Article first published online : 26 JAN 2011, DOI: 10.1111/j.1755-5922.2010.00258.x

  7. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence

    Birth Defects Research Part A: Clinical and Molecular Teratology

    Volume 94, Issue 8, August 2012, Pages: 576–598, Janine E. Polifka

    Article first published online : 17 JUL 2012, DOI: 10.1002/bdra.23027

  8. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers

    Pharmacoepidemiology and Drug Safety

    Volume 16, Issue 1, January 2007, Pages: 55–64, Marsha A. Raebel, David L. McClure, Steven R. Simon, K. Arnold Chan, Adrianne Feldstein, Susan E. Andrade, Jennifer Elston Lafata, Douglas Roblin, Robert L. Davis, Margaret J. Gunter and Richard Platt

    Article first published online : 8 FEB 2006, DOI: 10.1002/pds.1217

  9. You have free access to this content
    Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection

    Nephrology

    Volume 15, Issue s2, June 2010, Pages: 57–60, FAN FAN HOU and QIU GEN ZHOU

    Article first published online : 19 MAY 2010, DOI: 10.1111/j.1440-1797.2010.01315.x

  10. You have free access to this content
    Prevention and management of chronic kidney disease in type 2 diabetes

    Nephrology

    Volume 15, Issue s1, April 2010, Pages: S162–S194, Chadban S, Howell M, Twigg S, Thomas M, Jerums G, Cass A, Campbell D, Nicholls K, Tong A, Mangos G, Stack A, MacIsaac RJ, Girgis S, Colagiuri R, Colagiuri S and Craig J

    Article first published online : 1 APR 2010, DOI: 10.1111/j.1440-1797.2010.01240.x

  11. To RAS or Not to RAS? The Evidence for and Cautions with Renin-Angiotensin System Inhibition in Patients with Diabetic Kidney Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 5, May 2013, Pages: 496–514, Wendy L. St. Peter, Lauren E. Odum and Adam T. Whaley-Connell

    Article first published online : 9 APR 2013, DOI: 10.1002/phar.1232

  12. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease

    Intervention Review

    The Cochrane Library

    Pawana Sharma, Rachel C Blackburn, Claire L Parke, Keith McCullough, Angharad Marks and Corri Black

    Published Online : 5 OCT 2011, DOI: 10.1002/14651858.CD007751.pub2

  13. You have free access to this content
    Renin–angiotensin–aldosterone system blockade for cardiovascular diseases: current status

    British Journal of Pharmacology

    Volume 160, Issue 6, July 2010, Pages: 1273–1292, Terry KW Ma, Kevin KH Kam, Bryan P Yan and Yat-Yin Lam

    Article first published online : 12 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00750.x

  14. You have free access to this content
    Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation

    Journal of Internal Medicine

    Volume 261, Issue 6, June 2007, Pages: 577–586, G. Y. H. Lip, L. Frison, M. Grind and on Behalf of the SPORTIF Investigators and the SPORTIF Executive Steering Committee

    Article first published online : 26 FEB 2007, DOI: 10.1111/j.1365-2796.2007.01780.x

  15. You have free access to this content
    Treatment of Kidney Transplant Recipients With ACEi/ARB and Risk of Respiratory Tract Cancer: A Collaborative Transplant Study Report

    American Journal of Transplantation

    Volume 11, Issue 11, November 2011, Pages: 2483–2489, G. Opelz and B. Döhler

    Article first published online : 19 SEP 2011, DOI: 10.1111/j.1600-6143.2011.03681.x

  16. You have free access to this content
    Effects of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy After Hospital Discharge on Subsequent Rehospitalization for Acute Myocardial Infarction and Heart Failure

    Congestive Heart Failure

    Volume 15, Issue 4, July/August 2009, Pages: 170–175, Gregory Hess, 1,2 Ronald Preblick, 3 Jerrold Hill, 1 Craig A. Plauschinat and 1 Joseph Yaskin 4

    Article first published online : 5 MAY 2009, DOI: 10.1111/j.1751-7133.2009.00092.x

  17. The differential effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with respect to foot ulcer and limb amputation in those with diabetes

    Wound Repair and Regeneration

    Volume 18, Issue 5, September/October 2010, Pages: 445–451, David J. Margolis, Ole Hoffstad, Stephen Thom, Warren Bilker, Arturo R. Maldonado, Robert M. Cohen, Bruce J. Aronow and Timothy Crombleholme

    Article first published online : 14 SEP 2010, DOI: 10.1111/j.1524-475X.2010.00624.x

  18. You have free access to this content
    Angiotensin Inhibition After Myocardial Infarction: Does Drug Class Matter?

    Journal of General Internal Medicine

    Volume 21, Issue 12, December 2006, Pages: 1242–1247, Wolfgang C. Winkelmayer, Michael A. Fischer, Sebastian Schneeweiss, Raisa Levin and Jerry Avorn

    Article first published online : 9 AUG 2006, DOI: 10.1111/j.1525-1497.2006.00590.x

  19. Angiotensin converting enzyme inhibitor use soon after renal transplantation: a randomized, double-blinded placebo-controlled safety study

    Clinical Transplantation

    Volume 25, Issue 6, November/December 2011, Pages: 843–848, Daniel Glicklich, Roberto Gordillo, Katarina Supe, Raquel Tapia, Robert Woroniecki, Clemencia Solorzano and Maria Coco

    Article first published online : 16 DEC 2010, DOI: 10.1111/j.1399-0012.2010.01372.x

  20. Antihypertensive agents for preventing diabetic kidney disease

    Intervention Review

    The Cochrane Library

    Jicheng Lv, Vlado Perkovic, Celine V Foote, Maria E Craig, Jonathan C Craig and Giovanni FM Strippoli

    Published Online : 12 DEC 2012, DOI: 10.1002/14651858.CD004136.pub3